Undaloc, Victoria V.
HRN: 01-91-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/22/2023
08/28/2023
IV
500mg
Q8
T/c Acute Abdomen Sec To Ruptured Viscus, Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes